Company / Interest Expense per Share
Arcus Biosciences, Inc. Interest Expense per Share History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.10
FY2025
5-year range
$0.03 / $0.10
FY2024-FY2025
Trend
+268.5%
vs FY2024
Sector context
#25 of 43
Health Care
What the data says
At $0.10, Arcus Biosciences, Inc.'s interest expense per share ranks #19 of 43 in the Health Care sector.
Based on SEC 10-K filings.
0.10 in FY2025.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#19 of 43 in Health CareTop 42% of 43This company $0.10 Sector average $18.61
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share increased 268.5% year-over-year.
- Ranks #25 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.10 | +268.5% |
| FY2024 | $0.03 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026